# Orbsen Therapeutics Ltd. — Form D

Orbsen Therapeutics Ltd. of GALWAY, L2, a company, filed a Form D exempt-offering notice with the SEC on 2017-07-26. The offering totals $3.7M, of which $1.3M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2017-07-26
- Form: D
- Accession: 0001712617-17-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $3.7M
- Amount sold: $1.3M
- Remaining: $2.4M
- Minimum investment: $50K
- Investors: 11
- Date of first sale: 2017-01-19
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-291532

## Issuer

- Name: Orbsen Therapeutics Ltd.
- CIK: 0001712617
- Entity type: Limited Liability Company
- Jurisdiction: IRELAND
- Address: ORBSEN BUILDING, GALWAY, L2, H91DK59
- Phone: 353 91 528778

## Officers, directors & promoters (10)

| Name | Role | Location |
| --- | --- | --- |
| Francis Barry | Director | Galway, L2 |
| Chris Coughlan | Director | Galway, L2 |
| Larry Couture | Director | SAN DIEGO, CA |
| Gerry Cuddy | Director | Galway, L2 |
| Jim Fahy | Director | Galway, L2 |
| Jack Kavanaugh | Director | SAN DIEGO, CA |
| Timothy O'Brien | Director | Apple Valley, MN |
| Scott Tornblom | Director | Galway, L2 |
| Francis Barry | Executive Officer | Galway, L2 |
| Larry Couture | Executive Officer | SAN DIEGO, CA |

## More

- [CIK 1712617 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1712617&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001712617-17-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.